跳至主要内容
临床试验/IRCT20200127046282N2
IRCT20200127046282N2招募中2 期

Optimization of autologous melanocyte and keratinocyte cells suspention transplantation for vitiligo treatment

Tehran University of Medical Sciences0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
All

入选标准

  • Having no treatment within past 6 months, No pregnancy or breast-feeding, Have a diagnosis of vitiligo with depigmented patch more than 5 cm despite receiving at least 3 months active treatment, No infection at recipient site, No history of keloid and or koebner phenomenon, No history of active hepatitis the B, C, or AIDS, No active uncontrolled chronic systemic disease

排除标准

  • Vitiligo patients with active or progressive disease within last 12 months.

研究者

相似试验